imatinib mesylate has been researched along with Pulmonary Veno Occlusive Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hisada, R; Kato, M; Konno, S; Nakamura, J; Nakaya, T; Ohira, H; Sato, T; Shima, H; Sugimoto, A; Suzuki, M; Tsujino, I; Tsuneta, S; Watanabe, T | 1 |
| Matsubara, H; Miyaji, K; Ogawa, A | 1 |
| Aoki, T; Konno, R; Kozu, K; Miura, M; Sato, H; Satoh, K; Shimizu, T; Shimokawa, H; Sugimura, K; Tatebe, S; Yamamoto, S; Yaoita, N | 1 |
| Akagi, S; Ito, H; Matsubara, H; Nakamura, K; Ogawa, A; Sarashina, T | 1 |
| Boonstra, A; Overbeek, MJ; Smit, EF; van Nieuw Amerongen, GP; Vonk-Noordegraaf, A | 1 |
| Ikeda, D; Koiwa, H; Nishimura, M; Ohira, H; Tanino, M; Tsujino, I | 1 |
| Fukuda, K; Kataoka, M; Satoh, T; Yanagisawa, R; Yoshino, H | 1 |
2 review(s) available for imatinib mesylate and Pulmonary Veno Occlusive Disease
| Article | Year |
|---|---|
Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature.
Topics: Carbon Monoxide; Hemangioma, Capillary; Hemodynamics; Humans; Imatinib Mesylate; Lung Neoplasms; Pilot Projects; Pulmonary Artery; Pulmonary Veno-Occlusive Disease; Retrospective Studies | 2023 |
[Treatment with imatinib for refractory PAH].
Topics: Animals; Apoptosis; Becaplermin; Benzamides; Cell Proliferation; Clinical Trials as Topic; Female; Gene Expression; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Male; Middle Aged; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pulmonary Veno-Occlusive Disease; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Vasoconstriction | 2014 |
5 other study(ies) available for imatinib mesylate and Pulmonary Veno Occlusive Disease
| Article | Year |
|---|---|
Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Topics: Adult; Exercise Tolerance; Hemangioma, Capillary; Hemodynamics; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Kaplan-Meier Estimate; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Natriuretic Peptide, Brain; Protein Kinase Inhibitors; Pulmonary Veno-Occlusive Disease; Severity of Illness Index; Survival Rate; Treatment Outcome; Walk Test; Young Adult | 2017 |
Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease.
Topics: Female; Humans; Imatinib Mesylate; Middle Aged; Pulmonary Veno-Occlusive Disease; Radiography, Thoracic; Tomography, X-Ray Computed | 2019 |
Possible role of imatinib in clinical pulmonary veno-occlusive disease.
Topics: Benzamides; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Pulmonary Veno-Occlusive Disease; Pyrimidines; Vasodilator Agents | 2008 |
An autopsy case of pulmonary veno-occlusive disease refractory to imatinib.
Topics: Aged; Autopsy; Benzamides; Constriction, Pathologic; Drug Resistance; Female; Hemodynamics; Humans; Imatinib Mesylate; Lung; Piperazines; Pressure; Protein Kinase Inhibitors; Pulmonary Artery; Pulmonary Veno-Occlusive Disease; Pyrimidines; Tomography, X-Ray Computed | 2011 |
Sorafenib is effective in the treatment of pulmonary veno-occlusive disease.
Topics: Aged; Benzamides; Drug Therapy, Combination; Female; Hemodynamics; Humans; Imatinib Mesylate; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pulmonary Veno-Occlusive Disease; Pyrimidines; Sorafenib; Treatment Outcome | 2012 |